Introduction
A large body of clinical and experimental data indicates that decompressive craniectomy is an effective strategy to reduce early case fatality in the setting of uncontrolled intracranial hypertension due to brain swelling [1] [2] [3] [4] [5] [6] [7] .
Initially described by Kocher in 1901 for the treatment of posttraumatic brain edema [5] , this surgical option has recently been applied to patients with massive hemispheric cerebral infarction (so called 'malignant' MCA territory infarction with or without additional involvement of ACA or PCA territory), in whom the high mortality stems mainly from the development of extensive brain edema, increased intracranial pressure (ICP), and ensuing brain herniation [8] [9] [10] .
In this scenario, conventional medical therapies aimed at reducing intracranial pressure have, for the most part, proven to be ineffective, whereas releasing of the restriction of the dura mater and cranial vault, to allow the swollen infarcted brain tissue to expand outside, appears to offer a clear survival advantage, reducing mortality rate from 80% to approximately 20% [10] [11] [12] ; this seems to be related, at least theoretically, to the minimization, afforded by the surgical decompression, of pressure gradients that develop within the cranium in the presence of unilateral mass [1] . In fact, as globally increased intracranial pressure reduces cerebral perfusion pressure and cerebral blood flow, brain tissue shifts are likely to account for the early neurological deterioration seen in patients with an acute space-occupying lesion, such as the one represented by a unilateral mass of ischemic and edematous brain tissue compressing the healthy contralateral hemisphere [8, 9] . Equalizing the pressure differential between the two hemispheres via the surgical creation of a compensatory space, rather than treating the ICP per se with standard medical management, appears to be a more rational approach [1] .
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Keywords
Although a definite consensus exists regarding the crucial role that hemicraniectomy plays as a lifesaving strategy in the face of uncontrolled hemispheric brain edema, the benefit of this surgical technique in terms of reduced disability, however, has long been questioned, and patient selection criteria, as well as surgical timing, have become the focus of intense debate.
Due to their anecdotal and nonrandomized nature, data provided by previous research, suggesting reduced mortality and improved functional outcome in decompressed patients, have not been regarded strong enough to routinely implement this procedure in clinical practice [2-4, [13] [14] [15] [16] . In particular, concern has been raised that hemicraniectomy following hemispheric infarction may save lives but at the cost of an increased number of survivors with severe disability; in view of this controversy, some authors have favored an initially more conservative management, resorting to surgery only as a last-ditch salvage therapy for patients at the end stages of herniation.
Recently, however, new data from three European randomized controlled trials (namely DECIMAL, DES-TINY and HAMLET) seem to challenge the notion that decompressive surgery plays a merely lifesaving role in the setting of uncontrolled cerebral edema [16] [17] [18] 19 ]. A planned pooled analysis of these data showed that early decompressive surgery (48 h) improved functional outcome (modified Rankin score 4) for the predefined subgroups of age, presence of aphasia and time to randomization. Specifically, compared with medical therapy alone, surgery was associated with a 50% absolute risk reduction (ARR) of death [95% CI, 33-67], with more patients surviving with a slight-to-moderate disability (mRS of 2 or 3) [ARR of 23% (95% CI, 5-41)] or with a slight to moderately severe disability (mRS of 2, 3, or 4) [ARR of 51% (95% CI, 34-69)] [18] . Correct interpretation of these results is critically important to select the best patients and optimal timing of intervention, avoiding scenarios in which some patients may receive aggressive treatment unnecessarily, whereas others may be treated too late.
This review will take a comprehensive and critical look at the evidence supporting the use of decompressive craniectomy in malignant cerebral infarction, highlighting the range of outcomes expected in patients who undergo this procedure. We will draw upon recent clinical data derived from the randomized controlled trials that have been reported, and will also review the contributions that additional important studies in the existing literature have made. Ultimately, we will attempt to delineate an evidence-based, sensible approach to selecting decompressive surgery for patients with malignant hemispheric infarction.
Patient selection
Considerable research efforts have gone into identifying criteria that can help in selecting good candidates for surgical decompression among patients with hemispheric infarction [12, [20] [21] [22] [23] [24] [25] .
The first step is identifying which patients are at high risk for developing malignant cerebral edema. We want to avoid, on the contrary, unnecessary surgery in patients who would fare well without decompressive craniotomy, and to allow, on the contrary, timely intervention in patients at risk for fatal brain swelling.
The following clinical and neuroradiological features have been shown to be predictive of a malignant course after MCA infarction: initial National Institute of Health Stroke Scale (NIHSS) score at least 20 for dominant or at least 15 for nondominant strokes, younger age, early hypodensity of more than 50% of the MCA territory including the basal ganglia, additional involvement of the ipsilateral ACA or the PCA territories, and CTdocumented anteroseptal shift more than 5 mm or pineal shift more than 2 mm. Nevertheless, the observation that, despite the presence of these predictors, a significant proportion of patients may be spared from fatal brain swelling, has suggested the need to establish more objective neuroimaging criteria to identify those patients more likely to benefit from early, aggressive intervention. In this respect, a critical infarct volume of at least 145 ml on diffusion weighted MRI (DWI) has emerged as an additional strong predictor [16, 20, 21, 25] . This finding has been recently confirmed by the investigators of the DECIMAL trial, in which all patients with stroke volumes less than 145 cm 3 survived, whereas patients with infarct volumes of at least 145 cm 3 had a mortality rate of 77.8% in the absence of surgery. None of those with infarct volumes more than 210 cm 3 survived without craniectomy [16] .
Once the 'malignant' potential of an ischemic lesion has been recognized, a further and perhaps more crucial step is to determine the likelihood that implementation of the surgical option will have a major benefit on patient functional recovery, rather than merely increasing the chance of survival with the risk of associated major disability. Patients and family are generally more concerned about the potential for an unfavorable outcome represented by survival with devastating consequences on motor, verbal and cognitive functioning, than death per se. The hope for improved functional recovery with aggressive intervention may encourage a family toward a decision for surgery, whereas the fear of survival with severe impairment in the quality of life results often in surgical delays.
The challenge of timely identifying which patients are likely to benefit the most from decompressive craniotomy should be approached on the basis of an accurate assessment of specific pretreatment variables that have been explored with regard to their influence on functional outcome.
In this respect, a review of the literature, taking into account data from both retrospective and prospective analyses, as well as the most recent multicenter randomized trials, indicates unequivocally that age is the strongest predictor of disability and long-term dependence after decompressive hemicraniectomy for hemispheric infarction. Most of the studies report an age cut-off for functional benefit (i.e., survival with independency or acceptable degree of dependency) between 50 and 60 years [12, 16, 17, 24, [26] [27] [28] . Conversely, volume and laterality of infarction, pretreatment neurological status (i.e., low GCS, presence of anisocoria) and involvement of multiple vascular territories (i.e., additional infarction of ACA or PCA territory) have been identified, in nearly all reports, as nonsignificant variables in terms of prognostic relevance, although a trend toward better functional outcome with lower DWI infarct volume has been detected in the DECIMAL study, warranting further study into the correlation between these two parameters [16, 29, 30] .
In most of the studies looking at the impact of surgical decompression on poststroke disability, measures of functional outcome have been represented by the Barthel index and the modified Rankin scale (mRS) score, where a Barthel index 60 and an mRS score 3 or less identify favorable outcomes characterized by minimal-to-moderate disability (not requiring patient institutionalization), whereas a Barthel index less than 60 and an mRS of 4-6 define poor outcomes with moderately severe or very severe disability [16, 17, 24] .
In a systematic review of 138 hemicraniectomy cases by Gupta et al. [11] , the proportion of patients with severe disability (Barthel index <60, mRS >3) among those more than 50 years old was significantly higher than that observed among those 50 years old or less (80 versus 32%, respectively) [9] . Also, a mortality rate of 32% was detected in patients more than 50 years of age despite surgery, as compared to a mortality of 14% observed in patients less than 50 years of age. Retrospective analyses of other series, as well as several prospective studies, have yielded similar conclusion, indicating a prevalence of greater disability in patients older than 50 or 60 years, depending on the individual series [12, [31] [32] [33] [34] .
These observations of less favorable outcomes in older patients undergoing hemicraniectomy are also in agreement with the results of the pooled analysis of the three European randomized controlled trials DECIMAL, DESTINY and HAMLET, which shows a positive correlation between increasing age and risk of surviving with moderately severe disability (mRS ¼ 4), namely in a condition requiring assistance from others [16] [17] [18] 19 ].
Age limit and craniectomy
Although an impaired ability of the brain to compensate from a stroke, due to age-related loss of neuroplasticity, may represent a sufficient factor to account for the poor functional recovery observed in elderly patients, the contribution of more vascular risk factors and comorbidities (such as hypertension, coronary artery disease, cardiac arrhythmias, diabetes mellitus, arterial occlusive diseases) to the worst prognosis cannot be excluded [35] . Noteworthy among the earlier-mentioned medical conditions, preexisting hypertension has emerged, in a study from Pillai et al. [34] , as a significant predictor of death, regardless of the patient's age, and there is no reason to disregard a possible negative impact of this or other cardiovascular risk factors also on functional recovery. Intuitively, age-dependent comorbidities increase the risk for a vast array of nonneurological complications related to long-term intensive care management, as detailed by data reported in the DECIMAL trial, including pneumonia, sepsis, pulmonary embolism and cardiac failure, which may impact adversely the ability of the elderly to recover to largely independent status. These observations suggest, in our opinion, that definition and application of a risk stratification method that attributes greater prominence to the prestroke health status of older individuals, rather than to an absolute number represented by their age, may prove useful in guiding proper decision making with regard to the opportunity to undertake surgical decompression in this category of patients.
In conclusion, our knowledge of the natural history of the disease in the elderly is still hazy, and a significant good recovery potential after decompressive hemicraniectomy in subsets of this patient population that lack significant comorbidities cannot be entirely excluded and warrants further investigations.
Hemispheric dominance
A few notes need to be addressed to the controversial issue of offering decompressive surgery to patient with stroke in the dominant hemisphere. Some reports, viewing severe aphasia as having an unacceptable impact on quality of life, argue against decompression in dominant hemispheric strokes [2] . In fact, the possibility of severe disabling hemiplegia is often perceived by patients as an outcome worse than aphasia [36] . Similarly, nondominant strokes can sometimes also lead to deficits just as disabling as aphasia, including reduced cognitive abilities, emotional disorders, or multimodal neglect syndromes [37, 38] , which may interfere with acute rehabilitation and social reintegration. Data derived from a systematic review of the literature by Gupta et al. [11] , and from other recent reports, including the DECIMAL trial, refute the significance of laterality of infarction to functional outcome [12, 37, 39] . In particular, a subset analysis in the DECIMAL trial detected no significant difference in the mRS scores of survivors with or without aphasia, a finding further supported by the results of the pooled analysis of the three European trials. The presence of aphasia did not alter the benefit of surgery for preventing moderate-to-severe disability. Recent studies also indicate a potential for significant improvement of aphasia in patients with dominant hemisphere strokes who undergo decompressive hemicraniectomy [37] . An additional encouraging observation is that in the DESTINY trial the significant proportion of patients experiencing aphasia, among the surgical survivors, retrospectively agreed with their choice to undergo decompressive surgery.
Overall, we believe that dominance of infarction should not be viewed as an exclusion criterion for hemicraniectomy in otherwise appropriate candidates.
Timing of surgery
Another much debated issue pertains to the definition of the optimal time point for hemicraniectomy. Although some reports have suggested that 'prophylactic' decompression performed within 24 h after stroke onset, before signs of herniation are noted, may offer the greatest survival and functional advantage [4, 15, 28, 33] , other studies have failed to identify a link between worse prognosis and herniation syndrome [11, 12, 24, 31] . These studies encourage clinicians toward a more conservative approach, waiting for the development of clinical or radiological signs of mass effect before implementing the surgical option.
The pooled analysis of the three European randomized trials has clearly shown that hemicraniectomy for malignant MCA infarction can reduce mortality and improve functional outcome in patients treated within 48 h of stroke onset [18] , with no difference, however, in effect of surgery before or after 24 h.
Given that clinical signs of herniation are uncommon in the first 48 h, the question whether delayed hemicraniectomy could be still beneficial remained unanswered. In the HAMLET trial, in which patients were randomized up to 4 days after stroke onset, there was no benefit from surgery when delayed from 48 to 96 h after stroke onset [19 ] . Nevertheless, the small number of patients (25, i.e. 40%) included in the HAMLET study after 48 h limits definitive conclusions. At present, based on available results from the randomized trials, we recommend resorting to hemicraniectomy within the first 48 h. Considering that in most patients clinical and radiological signs of mass effect appear after 2 days of stroke onset, delaying surgery beyond the first 24 h, in order to allow more time for careful evaluation of surgical indications, appears, in our opinion, a well tolerated approach that is unlikely to jeopardize the chances of a good long-term outcome, provided that surgical treatment is promptly implemented at the first reversible signs of brain tissue shift.
Decompressive craniectomy in cerebellar strokes
Posterior fossa decompression (i.e. suboccipital decompressive craniectomy, with or without additional resection of necrotic cerebellar tissue) is generally accepted as an effective, lifesaving treatment for cerebellar swelling secondary to large infarction [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . This approach is generally undertaken with little hesitation in the appropriate candidates, as the neurological deficits stemming from loss of cerebellar tissue are far more acceptable than the overwhelming cognitive, emotional and motor dysfunctions that may result from a malignant MCA infarction. The possibility of rapidly progressive cerebellar edema causing acute obstructive hydrocephalus (from 4th ventricle displacement) and brainstem compression prompts early consideration of surgery in these patients [42, 43] . Specifically, progressive deterioration of consciousness or radiological demonstration of mass effect (such as obliteration of basal cisterns in the posterior fossa, or displacement or obliteration of the 4th ventricle), strongly suggest the need for early decompression (with or without ventriculostomy for the treatment of the coexisting hydrocephalus). The presence of brainstem infarction by MRI may discourage surgical intervention, as this has been associated with a poor outcome [29, 42, 44] . This observation has been recently confirmed by a study from Pfefferkorn et al. [29] , in which retrospective analysis of long-term outcome after decompressive surgery in a series of 57 patients with malignant cerebellar infarction revealed that preoperative neuroradiological evidence of brainstem infarction was the only variable associated with a mRS at least 4 at followup, whereas other factors such as older age (>60), low preoperative GCS, comorbidity, time to surgery, and bilateral cerebellar involvement lacked prognostic significance. In a previous study from Hornig et al. [45] , however, a correlation between age more than 60 and poor outcome was detected [45] . Also, a recent retrospective study from Juttler et al. [17] , analyzing long-term outcome in 56 patients surgically treated for space-occupying cerebellar infarction, found younger age to be an independent predictor of improved longterm survival and functional outcome, and higher GCS score at admission, an independent predictor of improved long-term survival [30] . Given the uncertainty of the prognostic value of age and preoperative GCS score, further evaluation of the correlation between these two parameters and long-term outcome in large prospective case series is warranted. Pending more data, it seems appropriate not to withhold life-saving posterior fossa decompressive surgery in patients older than 60 years or with poor preoperative GCS score.
Conclusion
In light of the compelling evidence provided by three European randomized trials, we believe that in the presence of factors predictive of an acceptable functional outcome, such as younger age (60 years old) and, perhaps more importantly, good prestroke functional status, the performance of decompressive hemicraniectomy within 48 h should be considered in patients with malignant hemispheric strokes, regardless of the involved hemisphere.
Conversely, when the chances of recovery without severe disability are deemed poor based on the identification of factors with negative prognostic impact (e.g., age >60 in the presence of a high number of vascular risk factors, multiple comorbidities, underlying dementia, or history of depression), a palliative approach aimed at providing comfort seems warranted in patients developing malignant hemispheric infarction, as the implementation of conventional medical strategies to lower ICP (osmotherapy, hyperventilation, hypothermia), in the absence of decompressive surgery, is not supported by adequate evidence of efficacy from experimental or clinical studies. Decompressive suboccipital craniectomy for postischemic cerebellar edema causing neurological deterioration or radiological evidence of mass effect is strongly indicated in the absence of additional brainstem infarction, regardless of the patient's age and the preoperative GCS score, as it is lifesaving and may ensure patient recovery with a relatively good quality of life. In subsets of patients with associated brainstem infarction, which predicts poor outcome, no optimal treatment strategy may be inferred from the current literature, and the decision to perform a life-saving surgical intervention in this setting should be made on an individual basis, being largely influenced by the degree of brainstem involvement.
